DELAWARE
|
22-1642321
|
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
(I.R.S.
Employer
Identification
No.)
|
Page
|
|
PART
I. FINANCIAL INFORMATION
|
|
Item
1. Financial
Statements
|
|
Consolidated
Statements of Operations and Comprehensive Income (Loss) for the
Quarters
and Nine Months Ended September 29, 2007 and September 30, 2006
(Unaudited)
|
1
|
Consolidated
Balance Sheets-September 29, 2007 (Unaudited) and December 30,
2006
|
2
|
Consolidated
Statement of Stockholders’ Equity for the Nine Months Ended September 29,
2007 (Unaudited)
|
3
|
Consolidated
Statements of Cash Flows for the Nine Months Ended September 29,
2007 and
September 30, 2006 (Unaudited)
|
4
|
|
|
Notes
to Consolidated Financial Statements
|
5
|
Item
2. Management's Discussion and
Analysis of Financial Condition and Results of Operations
|
14
|
Item
3. Quantitative and Qualitative
Disclosures about Market Risk
|
24
|
Item
4T. Controls and Procedures
|
24
|
PART
II. OTHER INFORMATION
|
|
Item
1. Legal Proceedings
|
24
|
Item
1A. Risk Factors
|
24
|
Item
5. Other
Information
|
25
|
Item
6. Exhibits
|
26
|
Signatures
|
27
|
Quarters
Ended
|
Nine
Months Ended
|
||||||||||||
September
29,
2007
|
September
30,
2006
|
September
29,
2007
|
September
30,
2006
|
||||||||||
CONTINUING
OPERATIONS
|
|||||||||||||
Net
sales
|
$
|
6,612,494
|
$
|
5,498,645
|
$
|
16,495,411
|
$
|
17,282,913
|
|||||
Costs
and expenses:
|
|||||||||||||
Cost
of sales
|
3,796,384
|
3,215,008
|
9,615,265
|
9,620,739
|
|||||||||
Selling,
general and administrative
|
2,099,038
|
2,221,596
|
6,292,769
|
6,706,503
|
|||||||||
Research
and development
|
399,980
|
578,511
|
1,219,487
|
1,402,141
|
|||||||||
6,295,402
|
6,015,115
|
17,127,521
|
17,729,383
|
||||||||||
Operating
income (loss)
|
317,092
|
(516,470
|
)
|
(632,110
|
)
|
(446,470
|
)
|
||||||
Interest
and other (expense) income, net
|
(72,196
|
)
|
52,640
|
(55,795
|
)
|
119,692
|
|||||||
Income
(loss) from continuing operations before income taxes
|
244,896
|
(463,830
|
)
|
(687,905
|
)
|
(326,778
|
)
|
||||||
Provision
(benefit) for income taxes
|
-
|
-
|
-
|
-
|
|||||||||
Income
(loss) from continuing operations
|
244,896
|
(463,830
|
)
|
(687,905
|
)
|
(326,778
|
)
|
||||||
DISCONTINUED
OPERATIONS
|
|||||||||||||
Loss
from discontinued operations before income taxes
|
(1,472,457
|
)
|
(147,737
|
)
|
(4,766,381
|
)
|
(243,905
|
)
|
|||||
Writedown
of net assets held for sale to fair value
|
(585,884
|
)
|
-
|
(585,884
|
)
|
-
|
|||||||
Provision
(benefit) for income taxes
|
-
|
(13,000
|
)
|
506,000
|
(61,000
|
)
|
|||||||
Loss
from discontinued operations
|
(2,058,341
|
)
|
(
134,737
|
)
|
(5,858,265
|
)
|
(182,905
|
)
|
|||||
Net
loss
|
$
|
(1,813,445
|
)
|
$
|
(598,567
|
)
|
$
|
(6,546,170
|
)
|
$
|
(509,683
|
)
|
|
Income
(loss) per common share from continuing operations - basic
|
$
|
.08
|
$
|
(.15
|
)
|
$
|
(.23
|
)
|
$
|
(.10
|
)
|
||
Loss
per common share from discontinued operations - basic
|
$
|
(.70
|
)
|
$
|
(.04
|
)
|
$
|
(1.97
|
)
|
$
|
(.06
|
)
|
|
Net
loss per common share - basic
|
$
|
(.62
|
)
|
$
|
(.19
|
)
|
$
|
(2.20
|
)
|
$
|
(.16
|
)
|
|
Income
(loss) per common share from continuing
operations - diluted
|
$
|
.08
|
$
|
(.15
|
)
|
$
|
(.23
|
)
|
$
|
(.10
|
)
|
||
Loss
per common share from discontinued operations - diluted
|
$
|
(.69
|
)
|
$
|
(.04
|
)
|
$
|
(1.97
|
)
|
$
|
(.06
|
)
|
|
Net
loss per common share - diluted
|
$
|
(.61
|
)
|
$
|
(.19
|
)
|
$
|
(2.20
|
)
|
$
|
(.16
|
)
|
|
Weighted
average number of shares outstanding - basic
|
2,917,245
|
3,137,241
|
2,974,757
|
3,143,377
|
|||||||||
Weighted
average number of shares outstanding - diluted
|
2,960,187
|
3,137,241
|
2,974,757
|
3,143,377
|
|||||||||
COMPREHENSIVE
LOSS
|
|||||||||||||
Net
loss
|
$
|
(1,813,445 | ) |
$
|
(598,567
|
) |
$
|
(6,546,170
|
)
|
$
|
(509,683
|
)
|
|
Comprehensive
income (loss):
|
|||||||||||||
Foreign
currency translation adjustment
|
88,179
|
(2,318
|
)
|
456,693
|
316,529
|
||||||||
Comprehensive
loss
|
$
|
(1,725,266
|
)
|
$
|
(600,885
|
)
|
$
|
(6,089,477
|
)
|
$
|
(193,154
|
)
|
|
September
29,
2007
|
December
30,
2006
|
|||||
|
(UNAUDITED)
|
(Note
1)
|
|||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
1,148,260
|
$
|
5,399,333
|
|||
Accounts
receivable, net
|
6,517,573
|
5,132,319
|
|||||
Inventories,
net
|
4,481,851
|
3,740,317
|
|||||
Other
current assets
|
776,482
|
833,543
|
|||||
Current
assets held for sale
|
1,044,334
|
1,615,814
|
|||||
Total
current assets
|
13,968,500
|
16,721,326
|
|||||
Property,
plant and equipment
|
37,580,094
|
36,626,348
|
|||||
Less
accumulated depreciation and amortization
|
26,490,857
|
24,850,616
|
|||||
Property,
plant and equipment, net
|
11,089,237
|
11,775,732
|
|||||
Restricted
cash
|
250,000
|
-
|
|||||
Other
assets
|
499,305
|
491,596
|
|||||
Deferred
tax assets
|
100,000
|
100,000
|
|||||
Long-term
assets held for sale
|
793,192
|
5,164,852
|
|||||
Total
Assets
|
$
|
26,700,234
|
$
|
34,253,506
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Current
portion of long-term debt
|
$
|
550,000
|
$
|
550,000
|
|||
Accounts
payable
|
682,072
|
758,344
|
|||||
Accrued
liabilities
|
1,246,672
|
1,077,169
|
|||||
Customer
deposits
|
356,044
|
203,783
|
|||||
Deferred
income taxes
|
100,000
|
100,000
|
|||||
Current
liabilities related to assets held for sale
|
1,151,180
|
677,554
|
|||||
Total
current liabilities
|
4,085,968
|
3,366,850
|
|||||
Long-term
debt, net of current portion
|
3,900,000
|
4,312,500
|
|||||
Deferred
liabilities
|
55,434
|
37,839
|
|||||
Long-term
liabilities related to assets held for sale
|
236,346
|
251,540
|
|||||
Total
liabilities
|
8,277,748
|
7,968,729
|
|||||
Commitments
and contingencies
|
|||||||
Stockholders'
equity:
|
|||||||
Preferred
stock, par value $.01 per share:
|
|||||||
Authorized:
1,000,000 shares
|
|||||||
No
shares issued
|
|||||||
Common
stock, par value $.01 per share:
|
|||||||
20,000,000
shares authorized; 3,288,388 and 3,265,638 shares issued; and 2,925,483
and 3,141,433 shares outstanding, respectively
|
32,884
|
32,656
|
|||||
Additional
paid-in capital
|
19,612,388
|
19,237,130
|
|||||
Retained
earnings
|
53,647
|
6,599,817
|
|||||
Accumulated
other comprehensive income
|
1,845,731
|
1,389,038
|
|||||
21,544,650
|
27,258,641
|
||||||
Less
treasury stock, at cost - 362,905 shares at September 29, 2007
and 124,205
shares at December 30, 2006
|
(3,122,164
|
)
|
(973,864
|
)
|
|||
Total
stockholders' equity
|
18,422,486
|
26,284,777
|
|||||
Total
Liabilities and Stockholders' Equity
|
$
|
26,700,234
|
$
|
34,253,506
|
Common
Stock
|
Additional
Paid-in
|
Retained
|
Accumulated
Other Comprehensive
|
Treasury
Stock
|
|||||||||||||||||||||
Shares
|
Amount
|
Capital(A)
|
Earnings
|
Income
|
Shares
|
Amount
|
Total
|
||||||||||||||||||
3,265,638
|
$
|
32,656
|
$
|
19,237,130
|
$
|
6,599,817
|
$
|
1,389,038
|
124,205
|
$
|
(973,864
|
)
|
26,284,777
|
||||||||||||
Net
loss
|
(6,546,170
|
)
|
(6,546,170
|
)
|
|||||||||||||||||||||
Share-based
compensation
|
223,007
|
|
223,007
|
||||||||||||||||||||||
Stock
Purchase Plan sales
|
10,450
|
105
|
78,544
|
|
78,649
|
||||||||||||||||||||
Exercise
of stock options
|
9,300
|
93
|
73,707
|
|
73,800
|
||||||||||||||||||||
Vesting
of restricted stock.
|
3,000
|
30
|
30
|
||||||||||||||||||||||
Repurchase
of common stock
|
|||||||||||||||||||||||||
for
the treasury
|
238,700
|
(2,148,300
|
)
|
(2,148,300
|
)
|
||||||||||||||||||||
Foreign
currency translation
|
456,693 | 456,693 | |||||||||||||||||||||||
Balance,
September 29, 2007
|
3,288,388
|
$
|
32,884
|
$
|
19,612,388
|
$
|
53,647
|
$
|
1,845,731
|
362,905
|
$
|
(3,122,164
|
)
|
$
|
18,422,486
|
Nine
Months Ended
|
|||||||
September
29,
2007
|
September
30,
2006
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
loss
|
$
|
(6,546,170
|
)
|
$
|
(509,683
|
)
|
|
Less,
Loss from discontinued operations
|
(5,858,265
|
)
|
(182,905
|
)
|
|||
Loss
from continuing operations
|
(687,905
|
)
|
(326,778
|
)
|
|||
Adjustments
to reconcile net loss from continuing operations to net cash used
in
operating activities:
|
|||||||
Depreciation
and amortization
|
1,756,945
|
1,759,143
|
|||||
Amortization
of deferred financing costs
|
22,755
|
37,440
|
|||||
Share-based
compensation
|
223,037
|
138,461
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable
|
(1,385,254
|
)
|
(1,295,186
|
)
|
|||
Inventories
|
(741,534
|
)
|
(515,381
|
)
|
|||
Other
current assets
|
57,061
|
(31,981
|
)
|
||||
Other
assets
|
(30,464
|
)
|
34,991
|
||||
Accounts
payable
|
(76,272
|
)
|
(21,655
|
)
|
|||
Accrued
liabilities
|
169,503
|
167,222
|
|||||
Customer
deposits
|
152,261
|
(669,152
|
)
|
||||
Deferred
liabilities
|
17,595
|
15,692
|
|||||
Net
cash used in operating activities of continuing operations
|
(522,272
|
)
|
(707,184
|
)
|
|||
Net
cash (used in) provided by operating activities of discontinued
operations
|
(363,141
|
)
|
276,892
|
||||
Net
cash used in operating activities
|
(885,413
|
)
|
(430,292
|
)
|
|||
Cash
flows from investing activities:
|
|||||||
Purchases
of capital assets
|
(1,070,450
|
)
|
(1,202,980
|
)
|
|||
Net
cash used in investing activities of continuing operations
|
(1,070,450
|
)
|
(1,202,980
|
)
|
|||
Net
cash used in investing activities of discontinued
operations
|
(
180,136
|
)
|
(44,767
|
)
|
|||
Net
cash used in investing activities
|
(1,250,586
|
)
|
(1,247,747
|
)
|
|||
Cash
flows from financing activities:
|
|||||||
Repurchase
of common stock for the treasury
|
(2,148,300
|
)
|
-
|
||||
Repayment
of borrowings
|
(412,500
|
)
|
(519,641
|
)
|
|||
Restricted
cash deposited
|
(250,000
|
)
|
-
|
||||
Proceeds
from the exercise of stock options
|
73,800
|
15,650
|
|||||
Proceeds
from Stock Purchase Plan sales
|
78,649
|
184,251
|
|||||
Net
cash used in financing activities of continuing operations
|
(2,658,351
|
)
|
(319,740
|
)
|
|||
Net
cash used in financing activities of discontinued
operations
|
(51,783
|
)
|
(1,102
|
)
|
|||
Net
cash used in financing activities
|
(2,710,134
|
)
|
(320,842
|
)
|
|||
Effect
of exchange rate changes
|
32,856
|
32,588
|
|||||
Net
decrease in cash and cash equivalents
|
(4,813,277
|
)
|
(1,966,293
|
)
|
|||
Cash
and cash equivalents at beginning of period, including $562,205
and
$422,960 reported under assets held for sale
|
5,961,537
|
4,081,330
|
|||||
Cash
and cash equivalents at end of period including $0 and $686,571
reported
under assets held for sale
|
$
|
1,148,260
|
$
|
2,115,037
|
|||
Supplemental
disclosures of cash flow information:
|
|||||||
Cash
paid during the period for:
|
|||||||
Interest
on credit facilities
|
$
|
272,644
|
$
|
179,702
|
|||
Non
cash activities:
|
|||||||
Repurchase
of common stock for treasury
|
$
|
-
|
$
|
399,998
|
|||
Loan
to officer-stockholder repaid through repurchase of common stock
for
treasury
|
$
|
-
|
$
|
400,000
|
Quarters
Ended
|
Nine
Months Ended
|
||||||||||||
September
29,
2007
|
September
30,
2006
|
September
29,
2007
|
September
30,
2006
|
||||||||||
|
|
|
|
||||||||||
Net
sales
|
$
|
1,003,317
|
$
|
1,256,286
|
$
|
2,824,301
|
$
|
4,082,344
|
|||||
Loss
before provision (benefit) for income taxes
|
(1,472,457
|
)
|
(147,737
|
)
|
(4,766,381
|
)
|
(243,905
|
)
|
|||||
Writedown
of net assets held for sale to fair value
|
(585,884
|
)
|
-
|
(585,884
|
)
|
-
|
|||||||
Provision
(benefit) for income taxes
|
-
|
(13,000
|
)
|
506,000
|
(61,000
|
)
|
|||||||
Net
loss
|
$
|
(2,058,341
|
)
|
$
|
(134,737
|
)
|
$
|
(5,858,265
|
)
|
$
|
(182,905
|
)
|
September
29,
2007
|
December
30,
2006
|
||||||
Cash
|
$
|
-
|
$
|
562,204
|
|||
Accounts
receivable
|
639,954
|
719,298
|
|||||
Inventories
|
251,789
|
177,156
|
|||||
Other
current assets
|
152,591
|
157,156
|
|||||
Current
assets held for sale
|
1,044,334
|
1,615,814
|
|||||
Property,
plant and equipment, net
|
793,192
|
1,209,633
|
|||||
Goodwill
|
-
|
3,503,219
|
|||||
Deferred
income taxes
|
-
|
452,000
|
|||||
Long-term
assets held for sale
|
793,192
|
5,164,852
|
|||||
Assets
held for sale
|
$
|
1,837,526
|
$
|
6,780,666
|
|||
Current
liabilities
|
$
|
1,151,180
|
$
|
677,554
|
|||
Long-term
debt
|
236,346
|
251,540
|
|||||
Liabilities
related to assets held for sale
|
$
|
1,387,526
|
$
|
929,094
|
Quarters
Ended
|
Nine
Months Ended
|
||||||||||||
September
29,
2007 |
September
30,
2006 |
September
29,
2007 |
September
30,
2006 |
||||||||||
|
|
|
|
||||||||||
Cost
of sales
|
$
|
25,000
|
$
|
8,000
|
$
|
54,000
|
$
|
23,000
|
|||||
Selling,
general and administrative
|
66,000
|
49,000
|
169,000
|
115,000
|
|||||||||
Total
share-based compensation
|
$
|
91,000
|
$
|
57,000
|
$
|
223,000
|
$
|
138,000
|
2007
|
2006
|
||||||
Expected
option life (years)
|
3.0
|
2.9
|
|||||
Expected
volatility
|
22.00
|
%
|
31.00
|
%
|
|||
Risk-free
interest rate
|
4.93
|
%
|
5.15
|
%
|
|||
Expected
dividend yield
|
0.00
|
%
|
0.00
|
%
|
|||
Fair
value per share of options granted
|
$
|
2.02
|
$
|
2.63
|
Weighted-
|
|||||||||||||
Weighted-
|
Average
|
||||||||||||
Average
|
Remaining
|
Aggregate
|
|||||||||||
Exercise
|
Contractual
|
Intrinsic
|
|||||||||||
Price
|
Shares
|
Term
|
Value
|
||||||||||
Outstanding
at December 30, 2006.
|
$
|
9.55
|
407,092
|
||||||||||
Granted
|
9.36
|
255,500
|
|||||||||||
Exercised
|
7.94
|
(9,300
|
)
|
||||||||||
Cancelled
|
12.55
|
(47,050
|
)
|
||||||||||
Outstanding
at September 29, 2007.
|
$
|
9.31
|
606,242
|
7.0
|
$
|
597,000
|
|||||||
Exercisable
at September 29, 2007.
|
$
|
9.22
|
292,742
|
4.4
|
$
|
436,000
|
Weighted-
|
|||||||
Average
|
|||||||
Grant-Day
|
|||||||
Fair
Value
|
Shares
|
||||||
Outstanding
at December 30, 2006
|
$
|
9.52
|
9,000
|
||||
Granted
|
9.78
|
10,500
|
|||||
Vested
|
9.52
|
(3,000
|
)
|
||||
Outstanding
at September 29, 2007
|
$
|
9.69
|
16,500
|
September
29,
2007
|
December
30,
2006
|
||||||
Finished
goods
|
$
|
40,619
|
$
|
345,519
|
|||
Work
in process
|
2,241,368
|
1,539,645
|
|||||
Raw
materials and purchased parts
|
2,199,864
|
1,855,153
|
|||||
Total
|
$
|
4,481,851
|
$
|
3,740,317
|
2007
|
2006
|
||||||
North
Fork Bank:
|
|||||||
Revolving
line of credit, 2.00% above LIBOR or 0.50% below prime
|
$
|
-
|
$
|
-
|
|||
Term
loan, due October 1, 2011, 2.25% above LIBOR or 0.50%
below prime |
1,600,000
|
1,900,000
|
|||||
Mortgage
loan, due October 1, 2016, 2.25% above LIBOR or 0.50%
below prime |
2,850,000
|
2,962,500
|
|||||
4,450,000
|
4,862,500
|
||||||
Less
current portion
|
550,000
|
550,000
|
|||||
Long-term
portion
|
$
|
3,900,000
|
$
|
4,312,500
|
Quarters
Ended
|
Nine
Months Ended
|
||||||||||||
September
29,
|
September
30,
|
September
29,
|
September
30,
|
||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Net
income (loss) available to common stockholders
|
$
|
(1,813,445
|
)
|
$
|
(598,567
|
)
|
$
|
(6,546,170
|
)
|
$
|
(509,683
|
)
|
|
Basic
net income (loss) per share
|
|||||||||||||
Weighted
average number of shares outstanding for basic net income (loss)
per
share-
|
|||||||||||||
Common
stock
|
2,917,245
|
3,137,241
|
2,974,757
|
3,143,377
|
|||||||||
Net
income (loss) per common share - basic
|
$
|
(.62
|
)
|
$
|
(.19
|
)
|
$
|
(2.20
|
)
|
$
|
(.16
|
)
|
|
Diluted
net income (loss) per share
|
|||||||||||||
Weighted
average number of shares outstanding for diluted net income (loss)
per
share:
|
|||||||||||||
Common
stock
|
2,917,245
|
3,137,241
|
2,974,757
|
3,143,377
|
|||||||||
Effect
of dilutive securities:
|
|||||||||||||
Stock
options (1)
|
42,942
|
-
|
-
|
-
|
|||||||||
Weighted
average number of shares outstanding for diluted net income (loss)
per
share
|
2,960,187
|
3,137,241
|
2,974,757
|
3,143,377
|
|||||||||
Net
income (loss) per common share - diluted
|
$
|
(.61
|
)
|
$
|
(.19
|
)
|
$
|
(2.20
|
)
|
$
|
(.16
|
)
|
(1)
|
Represents
additional shares resulting from assumed conversion of stock options
less
shares purchased with the proceeds
therefrom.
|
Diluted net income (loss) per share excludes 84,000 shares underlying stock options for the quarter ended September 29, 2007 as the exercise price of these options was greater than the average market value of the common shares, resulting in an anti-dilutive effect on net income (loss) per share. |
Because of the loss from continuing operations for the nine months ended September 29, 2007 and for the quarter and nine months ended September 30, 2006, approximately 606,000, 464,000 and 464,000 shares underlying stock options, respectively, were excluded from the calculation of diluted net income (loss) per share as the effect would be anti-dilutive. |
Quarters
Ended
|
Nine
Months Ended
|
||||||||||||
September 29,
2007 |
September
30,
2006 |
September
29,
2007 |
September
30,
2006 |
||||||||||
|
|
|
|
||||||||||
Net
sales
|
$
|
1,003,000
|
$
|
1,256,000
|
$
|
2,824,000
|
$
|
4,082,000
|
|||||
Loss
before provision (benefit) for income taxes
|
(1,472,000
|
)
|
(148,000
|
)
|
(4,766,000
|
)
|
(244,000
|
)
|
|||||
Writedown
of net assets held for sale to fair value
|
(586,000
|
)
|
-
|
(586,000
|
)
|
-
|
|||||||
Provision
(benefit) for income taxes
|
-
|
(13,000
|
)
|
506,000
|
(61,000
|
)
|
|||||||
Net
loss
|
$
|
(2,058,000
|
)
|
$
|
(135,000
|
)
|
$
|
(5,858,000
|
)
|
$
|
(183,000
|
)
|
Net
assets:
|
||||
Property,
plant and equipment, at cost
|
$
|
14,928,000
|
||
Less
accumulated depreciation and amortization
|
9,098,000
|
|||
Property,
plant and equipment, net
|
5,830,000
|
|||
Inventories
|
563,000
|
|||
Other
assets, net
|
146,000
|
|||
Total
net assets at September 29, 2007
|
6,539,000
|
|||
Commitments:
|
||||
Planned
equipment purchases for the remainder of 2007
|
525,000
|
|||
Lease
obligations through January 2011
|
640,000
|
|||
Total
commitments
|
1,165,000
|
|||
Total
net assets and commitments
|
$
|
7,704,000
|
·
|
declines
in the market value of inventory;
|
·
|
changes
in customer demand for inventory, such as cancellation of orders;
and
|
·
|
our
purchases of inventory beyond customer needs that result in excess
quantities on hand that may not be returned to the vendor or charged
back
to the customer.
|
Percentage
of Net Sales
|
Percentage
of Net Sales
|
||||||||||||
Quarters
Ended
|
Nine
Months Ended
|
||||||||||||
September
29,
|
September
30,
|
September
29,
|
September
30,
|
||||||||||
Continuing
operations
|
2007
|
2006
|
2007
|
2006
|
|||||||||
Net
sales
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
|||||
Costs
and expenses:
|
|||||||||||||
Cost
of sales
|
57.4
|
58.5
|
58.3
|
55.7
|
|||||||||
Selling,
general and administrative
|
31.7
|
40.4
|
38.1
|
38.8
|
|||||||||
Research
and development
|
6.1
|
10.5
|
7.4
|
8.1
|
|||||||||
95.2
|
109.4
|
103.8
|
102.6
|
||||||||||
Operating
income (loss)
|
4.8
|
(9.4
|
)
|
(3.8
|
)
|
(2.6
|
)
|
||||||
Interest
and other (expense) income, net
|
(1.1
|
)
|
1.0
|
(0.4
|
)
|
0.7
|
|||||||
Income
(loss) from continuing operations before income taxes
|
3.7
|
(8.4
|
)
|
(4.2
|
)
|
(1.9
|
)
|
||||||
Provision
(benefit) for income taxes
|
-
|
-
|
-
|
-
|
|||||||||
Income
(loss) from continuing operations
|
3.7
|
(8.4
|
)
|
(4.2
|
)
|
(1.9
|
)
|
||||||
Loss
from discontinued operations before income taxes
|
(22.3
|
)
|
(2.7
|
)
|
(28.9
|
)
|
(1.4
|
)
|
|||||
Writedown
of net assets held for sale to fair value
|
(8.8
|
)
|
-
|
(3.6
|
)
|
-
|
|||||||
Provision
(benefit) for income taxes
|
-
|
(0.2
|
)
|
3.0
|
(0.4
|
)
|
|||||||
Loss
from discontinued operations
|
(31.1
|
)
|
(2.5
|
)
|
(35.5
|
)
|
(1.0
|
)
|
|||||
Net
loss
|
(27.4
|
)%
|
(10.9
|
)%
|
(39.7
|
)%
|
(2.9
|
)%
|
2007
|
2006
|
||||||
Beginning
backlog
|
$
|
11,490,000
|
$
|
12,049,000
|
|||
Plus
orders
|
21,767,000
|
15,307,000
|
|||||
Less
net sales
|
16,495,000
|
17,283,000
|
|||||
Ending
backlog
|
$
|
16,762,000
|
$
|
10,073,000
|
|||
Book-to-bill
ratio
|
1.32
|
0.89
|
Quarter
ended September 29, 2007
|
Quarter
ended September 30, 2006
|
|||||||||||||||||||
$
|
Increase/
(Decrease) from prior period |
%
of
Net Sales |
$
|
Increase/
(Decrease) from prior period |
%
of
Net Sales |
|||||||||||||||
Consolidated
gross
profit
|
$
|
2,816,000
|
$
|
532,000
|
42.6
|
%
|
$
|
2,284,000
|
$
|
(424,000
|
)
|
41.5
|
%
|
Nine
Months ended September 29, 2007
|
Nine
Months ended September 30, 2006
|
|||||||||||||||||||
$
|
Increase/
(Decrease) from prior period |
%
of
Net Sales |
$
|
Increase/
(Decrease) from prior period |
%
of
Net
Sales
|
|||||||||||||||
Consolidated
gross
profit
|
$
|
6,880,000
|
$
|
(782,000
|
)
|
41.7
|
%
|
$
|
7,662,000
|
$
|
(490,000
|
)
|
44.3
|
%
|
EXHIBIT
NUMBER |
DESCRIPTION
OF EXHIBIT
|
|
31.1+
|
Chief
Executive Officer's Certificate, pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
31.2+
|
Chief
Financial Officer's Certificate, pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
32.1+
|
Chief
Executive Officer's Certificate, pursuant to 18 U.S.C. Section 1350,
as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
|
32.2+
|
Chief
Financial Officer's Certificate, pursuant to 18 U.S.C. Section 1350,
as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
Date:
November 13, 2007
|
By:
|
/s/
Mason N. Carter
|
Mason
N. Carter
|
||
Chairman,
President and
|
||
Chief
Executive Officer
|
By:
|
/s/
Robert V. Condon
|
|
Robert
V. Condon
|
||
Vice
President, Finance and
|
||
Chief
Financial Officer
|